Adherence and quality of life in women with breast cancer being treated with oral hormone therapy

[1] Burstein HJ(2014)Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice guideline focused update J Clin Oncol 32 2255-2269

[2] Temin S(1998)Tamoxifen in the treatment of breast cancer N Engl J Med 339 1609-1618

[3] Anderson H(2002)An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane Cancer 95 2006-2016

[4] Buchholz TA(2011)Current treatment options for vulvovaginal atrophy Expert Rev Obstet Gynecol 6 141-151

[5] Davidson NE(2014)Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial Lancet 383 1041-1048

[6] Gelmon KE(2008)Effective oral chemotherapy for breast cancer: pillars of strength Ann Oncol 19 212-222

[7] Giordano SH(2001)Answering patients’ needs: oral alternatives to intravenous therapy Oncologist 6 12-16

[8] Hudis CA(2003)A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents Clin J Oncol Nurs 7 5-9

[9] Rowden D(2003)Patient education: the cornerstone of successful oral chemotherapy treatment Clin J Oncol Nurs 7 21-24

[10] Solky AJ(2011)Acceptance of oral chemotherapy in breast cancer patients—a survey study BMC Cancer 11 459-478

[1] Burstein HJ(2014)Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice guideline focused update J Clin Oncol 32 2255-2269

[2] Temin S(1998)Tamoxifen in the treatment of breast cancer N Engl J Med 339 1609-1618

[3] Anderson H(2002)An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane Cancer 95 2006-2016

[4] Buchholz TA(2011)Current treatment options for vulvovaginal atrophy Expert Rev Obstet Gynecol 6 141-151

[5] Davidson NE(2014)Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial Lancet 383 1041-1048

[6] Gelmon KE(2008)Effective oral chemotherapy for breast cancer: pillars of strength Ann Oncol 19 212-222

[7] Giordano SH(2001)Answering patients’ needs: oral alternatives to intravenous therapy Oncologist 6 12-16

[8] Hudis CA(2003)A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents Clin J Oncol Nurs 7 5-9

[9] Rowden D(2003)Patient education: the cornerstone of successful oral chemotherapy treatment Clin J Oncol Nurs 7 21-24

[10] Solky AJ(2011)Acceptance of oral chemotherapy in breast cancer patients—a survey study BMC Cancer 11 459-478